Biosig Technologies Inc (BSGM)

Overview News Price History Option Chain Discussions Forecast Stock Split

Biosig Technologies Inc stock is currently priced at $1.48, with a 24-hour trading volume of 81,377. It has seen a -4.82% decreased in the last 24 hours and a +174.58% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $1.48 pivot point. If it approaches the $1.37 support level, significant changes may occur.

Biosig Technologies Inc Stock (BSGM) Financials Data

Biosig Technologies Inc (BSGM) Revenue 2024

BSGM reported a revenue (TTM) of $283.00 thousand for the quarter ending March 31, 2023, a -14.50% decline year-over-year.

Biosig Technologies Inc (BSGM) Net Income 2024

BSGM net income (TTM) was -$29.95 million for the quarter ending September 30, 2023, a -4.22% decrease year-over-year.

Biosig Technologies Inc (BSGM) Cash Flow 2024

BSGM recorded a free cash flow (TTM) of -$18.73 million for the quarter ending September 30, 2023, a +20.58% increase year-over-year.

Biosig Technologies Inc (BSGM) Earnings per Share 2024

BSGM earnings per share (TTM) was -$4.80 for the quarter ending September 30, 2023, a +36.00% growth year-over-year.

Biosig Technologies Inc Stock (BSGM) Latest News

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Benzinga

BioSig Engages Consulting Firm for Business Model Strategies

GlobeNewswire Inc.

Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

Benzinga

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.